You are invited to watch this series of seven video chapters from a live medical expert broadcast that took place on 28 September 2018. Dr. Deepti Radia and Professor Richard Schlenk talk about advanced SM in the context of the EU approval of RYDAPT in all 3 subtypes of advanced SM.
In this video, Dr. Radia summarises the three types of advanced SM.
In this video, Dr. Radia discusses the role of abnormal mast cells in mastocytosis.
In this video, Dr. Radia and Dr. Schlenk discuss the clinical presentation and cornerstones of diagnosis.
In this video, Dr. Radia discusses the challenges of identifying SM with an associated hematological neoplasm (SM-AHN).
In this video, Dr. Radia and Dr. Schlenk discuss a hypothetical patient from initial symptoms through referrals, new diagnosis, and treatment.
In this video, Dr. Radia presents the efficacy and safety of RYDAPT, with data from the pivotal D2201 clinical trial.
In this video, Dr. Radia responds to questions regarding her own experience in treating patients with advanced SM.